[Other] 10.1038/s41586-026-10918-5 |
|
This post will be closed automatically in 2026-09-28 14:38
Reward20points
|
20
First-in-human phase 1 study of MK-1248, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody, as monotherapy or in combination with pembrolizumab in patients with advanced solid tumors.
20
Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475.
20
Characterization of Coping with Primary Dysmenorrhea in Women according to Their Level of Physical Activity: A Cross-Sectional Observational Study
20
Design of a machine learning to classify health beverages preferences for elderly people: an empirical study during COVID-19 in Thailand
20
Combinatorial innovation: Unpacking the genius of India＊s Unified Payments Interface
